Associate Professor Lisa Hall
Researcher biography
Dr Lisa Hall is Associate Professor of Epidemiology at the University of Queensland in Brisbane, Australia.
Teaching: Lisa has experience lecturing at both undergraduate and postgraduate levels, in a range of public health and research methods courses. She is a Senior Fellow of the Higher Education Academy. At UQ she is the Program Director for the Masters of Epidemiology, a flagship program within the School of Public Health.
Research: Lisa is an active health services researcher with expertise in epidemiology, implementation science and economic evaluation. Lisa's work examines not only the effectiveness, but also the cost-effectiveness, feasibility and sustainability of health services. Her current research focuses on the interface between evidence, policy and implementation to improve the surveillance and prevention of healthcare associated infections. Lisa is a Chief Investigator on several large NHMRC funded projects - the National Centre for Infections in Cancer, and the Researching Effective Approaches for Cleaning in Hospitals (REACH) Project. She is a member of the Research Committee and the External Affairs Committee for the Society for Healthcare Epidemiology of America. She is also an Adjunct Associate Professor at the Australian Centre for Health Services Innovation based at QUT.
Policy Experience: Lisa has significant policy experience at statewide and national levels. Prior to returning to academia in 2013, Lisa was a senior manager at the state health department of Queensland - responsible for the design, implementation and evaluation of infection prevention programs and policy. Lisa is currently a technical expert for several committees for the Australian Commission on Safety and Quality in Healthcare.
Featured projects | Duration |
---|---|
Contextual factors that influence antibiotic prescribing: a discrete choice experiment of GP registrars Centre for Research Excellence in Minimising Antibiotic Resistance in the Community (CRE-MARC) |
|
General model for assessing the cost effectiveness of AMS in primary care Centre for Research Excellence in Minimising Antibiotic Resistance in the Community (CRE-MARC) |
|
Brighton Hub Evaluation | |
Examining the complexities of the community networks limiting the uptake of biosimilar medications in the Australian healthcare system |